UBS Group’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8K | Sell |
|
|||||
|
2025
Q1 | $16K | Buy |
|
|||||
|
2024
Q4 | $6.46K | Sell |
|
|||||
|
2024
Q3 | $19.3K | Buy |
|
|||||
|
2024
Q2 | $576 | Buy |
|
|||||
|
2024
Q1 | $604 | Buy |
|
|||||
|
2023
Q4 | $409 | Hold |
|
|||||
|
2023
Q3 | $369 | Hold |
|
|||||
|
2023
Q2 | $449 | Sell |
|
|||||
|
2023
Q1 | $3.59K | Buy |
|
|||||
|
2022
Q4 | $545 | Sell |
|
|||||
|
2022
Q3 | $9K | Buy |
|
|||||
|
2022
Q2 | $8K | Buy |
|